Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus

Even in the era of successful combination antiretroviral therapy (cART), co-infection of Hepatitis C virus (HCV) remains one of the leading causes of non-AIDS-related mortality and morbidity among HIV-positive individuals as a consequence of accelerated liver fibrosis and end-stage liver disease (ES...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansari, AW Wahid, Schmidt, Reinhold E, Shankar, Esaki M, Kamarulzaman, Adeeba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272802/
https://www.ncbi.nlm.nih.gov/pubmed/25528160
http://dx.doi.org/10.1186/s12967-014-0341-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272802/
https://www.ncbi.nlm.nih.gov/pubmed/25528160
http://dx.doi.org/10.1186/s12967-014-0341-8

Ejemplares similares